AGP Executive Report
Last update: 2 hours agoHemp THC Crackdown: Texas’ Supreme Court-backed move tightens rules on hemp-derived THC, with retailers warning the lack of clear product definitions could trigger everything from license suspensions to felony exposure. Federal Policy Shock: A new U.S. federal ban on intoxicating hemp products would use a “total THC” standard and a 0.4 mg per-container cap, potentially making most current delta-8/HHC-style goods federally unlawful. Medicinal Cannabis Trials: Avecho’s pivotal cannabidiol insomnia study cleared an independent monitoring board checkpoint and restarted final-stage recruitment under the original design. Company Updates (ASX): Botanix reported early full-period commercial activity for its Sofdra program; Avecho, Emyria (Empax clinic rollout), Little Green Pharma (Cannatrek integration), and Neurotech (cannabinoid autism program) all drew investor attention. Enforcement & Seizures: Sri Lanka Customs seized 5.137 kg of Kush cannabis and hashish from two Thai nationals at the airport; Nigeria’s NDLEA probe also surfaced after a truck allegedly carrying 2,145 kg of cannabis—NNPC says it doesn’t own the vehicle. Retail/Access: Alabama opened a new medical dispensary in Talladega, aiming to reduce travel for qualifying patients.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
